fbpx Interview with Dr Stefan Vanthuyne about schizophrenia in practice | Progress In Mind

Interview with Dr Stefan Vanthuyne about schizophrenia in practice

Interview with Dr Stefan Vanthuyne, The Netherlands about talking to patients with schizophrenia and other important issues.

Q. When you first tell a patient they have schizophrenia, do you tell them this is a lifelong condition?

 A. Patients are told it is a chronic condition but one that, with appropriate treatment, can allow them to still have a quasi-normal life.

Q. Having made a diagnosis of schizophrenia – do you tell patients at that point how long they are likely to need to be on medication?

A. Patients normally would be on lifelong medication. In the case of a single, short episode of psychosis, therapies might be reviewed after 2-3 years.

Q. What factors have a large contribution to the quality of life of a patient with schizophrenia?

A. Medication can contribute greatly to a patient’s quality of life. This is usually given in conjunction with education of the patient and their family so they know about the disease, psychotherapy (the choice of which depends on the individual patient’s needs) and systemic therapy with the families.

Q. What methods do you employ to preserve or improve the quality of life of your patients with schizophrenia?

A. Each patient is given a treatment plan and referrals to the appropriate in-house specialist are made. In general, 60% of patients respond relatively well to this approach. More difficult cases are treated as needed.

Compliance with therapy is very important to each patient’s quality of life and discussions about this topic are held with every patient at the outset of therapy – usually long-acting medications are given.

Q. Do you think of schizophrenia as a neurodevelopmental disorder or as a neurodegenerative disease?

A. Although the debate is on-going, there is evidence to support schizophrenia having components of both a neurodevelopmental disorder and a neurodegenerative disease.

Q. What proportion of patients with schizophrenia have the potential to achieve improvements in relationships?

A. Most patients, with the understanding and support of family and friends and more widespread acceptance of patients with schizophrenia within society generally, have the potential to achieve improvements in their relationships. Future education will help promote further tolerance and understanding.

The views and opinions expressed on this page do not necessarily reflect those of Otsuka and Lundbeck.
You are leaving Progress in Mind
Le informazioni contenute nel nuovo sito prescelto possono non essere conformi al D.Ivo 219/06 che regola la pubblicità dei medicinali per uso umano e le opinioni espresse non riflettono necessariamente le posizioni dell’azienda, non sono da essa avvallate.
Accesso riservato a Operatori Sanitari
Per accedere si prega di registrarsi o, in caso sia già stato fatto, di autenticarsi
L’accesso a Progress in Mind Italia è consentito unicamente agli Operatori Sanitari (medici e farmacisti). I contenuti di questo sito sono prodotti da un team di Operatori Sanitari il cui obiettivo è presentare le ultime novità in ambito psichiatrico e neurologico, attraverso interviste, registrazioni audio/video di seminari con opinion leader, report e sintesi di congressi sia internazionali che nazionali. Per poter accedere al sito è quindi necessario registrarsi e fornire alcuni dati così da poter verificare che l‘utente sia un Operatore Sanitario.
Please confirm your email
We have just sent you an email, with a confirmation link.
Before you can gain full access - you need to confirm your email.
The information on this site is exclusively intented for health care professionals.
All the information included in the Website is related to products of the local market and, therefore, directed to health professionals legally authorized to prescribe or dispense medications with professional practice. The technical information of the drugs is provided merely informative, being the responsibility of the professionals authorized to prescribe drugs and decide, in each concrete case, the most appropriate treatment to the needs of the patient.
Register for access to Progress in Mind in your country